Health News

Breakthrough and Enovis (TM) Announce Official Partnership, Empowering Private Practice Healthcare to Help Improve Quality of Care While Increasing Profitability

Breakthrough and Enovis (TM) Announce Official Partnership, Empowering Private Practice Healthcare to Help Improve Quality of Care While Increasing ProfitabilityConservative care private practice owners can leverage Breakthrough’s exclusive marketing campaigns to promote Enovis™ Corporation’s innovative therapeutic technologies directly to patients.

Breakthrough and Enovis (TM) Announce Official Partnership, Empowering Private Practice Healthcare to Help Improve Quality of Care While Increasing Profitability
Enovis\u2122 and Breakthrough Announce Official Partnership
Through this new partnership, conservative care practice owners can reach more patients and overcome declining reimbursements by promoting high-tech, cash-based services directly to patients.


LOS ANGELES, September 11, 2023 (Newswire.com)
–
Breakthrough, a leader in conservative care marketing solutions, together with Enovis™ Corporation, a pioneer in innovative rehabilitation technologies and parent company to ChattanoogaⓇ & LightForceⓇ is excited to announce their official partnership. 

Enovis™ offers clinically differentiated rehabilitation technologies that help to enhance patient outcomes; Breakthrough offers data-driven healthcare marketing solutions. Breakthrough’s Patient Demand marketing software now offers multiple options for turnkey, data-driven campaigns designed to promote Chattanooga® & LightForce® technology directly to patients.

Through this new partnership, conservative care practice owners can reach more patients and overcome declining reimbursements by promoting high-tech, cash-based services directly to patients.

Stronger revenue potential will allow clinics to confidently adopt innovative therapeutic technologies, helping to improve quality of care nationwide.

“We understand the concerns private practice owners face in today’s market,” said Carl Mattiola, CEO of Breakthrough. “Our goal is to help practices educate patients directly so they can make informed decisions about their health; our software makes that marketing work as streamlined as possible for busy clinicians. We’re thrilled to add exclusive Enovis™ campaigns to our library of marketing solutions. This will help an immense number of patients gain access to therapies they wouldn’t experience otherwise.”

“As a leading medical technology company, Enovis™ is focused on developing innovative solutions that generate better patient outcomes. Part of our mission is to help healthcare professionals thrive, and we are thrilled about what this partnership with Breakthrough means for our customers and their businesses,” said Guy Guglielmino, President of Enovis™ Recovery Sciences.

Enovis™ and Breakthrough developed this exclusive partnership to support private practice and clinic owners in conservative healthcare, enhance patient engagement, and drive the adoption of innovative, clinically differentiated therapeutic technologies.

“Combining innovative cash-based services with tailored marketing campaigns is a win-win: private practices can help improve patient outcomes, and this partnership gives clinics the tools they need to thrive despite current economic challenges,” said Chad Madden, Co-Founder of Breakthrough. 

Many insurance companies do not reimburse for treatments made possible by modern medical technologies, such as laser therapy. Patients are often unaware of these affordable self-pay rehabilitative options.

Through education-focused marketing campaigns, private practice clinicians can promote cash-pay therapeutic services and increase their profit margins despite declining reimbursements.

Private practice owners and conservative care clinicians could experience strong revenue growth when investing in LightForceⓇ Laser Therapy, Radial Pressure Wave Therapy, and Traction Therapy from ChattanoogaⓇ, as well as other therapeutic modalities from Enovis™ Corporation. 

“Breakthrough’s system is really helpful for getting patients in the door & getting the word out about our LightForceⓇ Laser cash services,” says Tony Cere, owner of Kinetix PT in Gainesville, FL. “To make a big investment like that, you’ve got to know you can bring in the income. With Breakthrough, we didn’t have to worry.”

Clinicians will be better able to engage potential patients directly, drive awareness of affordable cash-based treatment options, secure better profit margins, and help positively impact patient outcomes.

For more information about the new partnership, visit https://getbreakthrough.com/enovis

Contact Information:

Andrea Sanders

Senior Marketing Manager

[email protected]

Original Source:

Breakthrough and Enovis (TM) Announce Official Partnership, Empowering Private Practice Healthcare to Help Improve Quality of Care While Increasing Profitability

Editor
Read More
Health News

Physicians for Informed Consent States, ‘For Normal-Risk Children, the Polio Vaccine is Not Proven Safer Than Polio Infection’

Physicians for Informed Consent States, ‘For Normal-Risk Children, the Polio Vaccine is Not Proven Safer Than Polio Infection’New Educational Materials Provide Important Data on Polio and the Polio Vaccine


NEWPORT BEACH, Calif., September 7, 2023 (Newswire.com)
–
Physicians for Informed Consent (PIC) has introduced two new educational documents, “Polio: What Parents Need to Know” and “IPV Vaccine: Is It Safer Than Polio?” Packed with key statistical data on the risk of polio as well as the risk of the IPV (inactivated poliovirus) vaccine, the documents assist parents in making a more informed risk-benefit calculation for vaccination. 

“Now more than ever, people have concerns about vaccines on the childhood vaccination schedule, and a question we hear all the time is ‘What about polio?'” said Greg Glaser, general counsel and national coalition director for Physicians for Informed Consent. “These new documents scientifically address this question, so more parents can research the vaccine and decide what’s best for their children.” 

The following is a summary of essential facts included in the documents.

Polio – Disease Information Statement (DIS):

  • About 95% of people who contract polio have no symptoms (asymptomatic).
  • The great majority of polio infections that are fatal or result in permanent paralysis occur in people who have had their tonsils surgically removed (tonsillectomy) or do not rest after feeling sick. 
  • Before the introduction of the polio vaccine in 1955, paralytic poliomyelitis was a disease of low incidence, occurring in about 1 in 22,000 or 0.005% in the U.S. population. 
  • Before the polio vaccine was introduced, about 0.0005% (1 in 190,000) of children at normal risk contracted polio that was fatal or led to permanent paralysis.

Polio  – Vaccine Risk Statement (VRS):

  • The polio vaccine does not prevent asymptomatic infection or transmission.
  • The Institute of Medicine has not ruled out the possibility that IPV vaccination can lead to Guillain-Barré syndrome or sudden infant death syndrome (SIDS).
  • Seizures may occur in about 1 in 829 children vaccinated with IPV vaccine.
  • A study published in the Journal of the American Medical Association (JAMA) shows an IPV-containing vaccine may cause permanent injury 38 times more often than permanent injury from polio infection.
  • The polio vaccine has not been proven safer than polio infection for normal-risk children.

“As polio is so feared in our culture, the data we reveal is paradigm-shifting,” said Dr. Shira Miller, founder and president of Physicians for Informed Consent. “Our educational documents show that for normal-risk children the polio vaccine is not proven safer than polio infection — which has serious implications for both children’s health and vaccine mandates for school attendance.”

To protect and enhance children’s health, it’s necessary that parents have access to reliable infectious disease and vaccine educational information. PIC makes scientific data freely available through its education program, a growing collection of concise, reader-friendly educational materials that support parents, physicians, and policymakers in calculating the risk-benefit ratio of vaccination. To read the newest DIS and VRS documents on polio and the IPV vaccine, visit physiciansforinformedconsent.org/polio.

Contact Information:

Greg Glaser

General Counsel

[email protected]

925-642-6651

Original Source:

Physicians for Informed Consent States, ‘For Normal-Risk Children, the Polio Vaccine is Not Proven Safer Than Polio Infection’

Editor
Read More